Versamet Royalties Corporation
VMETVersamet Royalties Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is between stages. Underneath, the last four quarters read mixed. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Versamet Royalties Corporation trades at $9.6, between stages. That is −6.6% against its own 200-day average. It sits at 52% of a 52-week range of $5 to $14. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (5 weeks and counting).
Today the stock is between stages. At $9.6 it trades −6.6% versus its 200-day average and sits at 52% of its 52-week range ($5–$14).
Against the market, two honest reads. Cumulative: over the last 11 months the stock moved +78% while the S&P 500 moved +20% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (5 weeks and counting; last ahead the week of 2026-07-02) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Versamet Royalties Corporation trades at 32.4× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 32.4× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Versamet Royalties Corporation reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 6 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +200.0% | — | — | — |
| Stock price | +78.1% | — | — | — |
4-Factor Sector Score
56.6/100 — rank 11 of 17 in Other Precious Metals & Mining · 44% evidence confidence · provisional, ranked below fully-evidenced peers
Versamet Royalties Corporation scores 56.6 out of 100 against the 17 companies it is compared with in Other Precious Metals & Mining, ranking 11. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 21.6 + 15.3 + 9.7 + 10 = 56.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Versamet Royalties Corporation reported $0.0 B of revenue in the Mar 26 quarter. The last full year, FY25, came in at $0.0 B. The last four reported quarters add to $0.1 B. A multi-year compound rate is not shown because the annual history behind it is too short to compute one honestly.
FY25 revenue came in at $0.0 B (+200.0% on the year). The latest quarter (Mar 26) printed $0.0 B, null year on year.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Versamet Royalties Corporation's operating margin is 100.0% in the Mar 26 quarter.
The latest quarter's operating margin is 100.0%, null pp against the same quarter a year ago. Across 2 fiscal years the operating margin has ranged 0.0%–133.3%.
Why: the numbers show the operating margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Versamet Royalties Corporation earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. That is 50.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 1 of the last 9 reported quarters were loss-making.
Mar 26 profit was $0.0 B, null year on year. On the full year, FY25 printed $0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Versamet Royalties Corporation's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.0 B of operating cash against $0.0 B of profit. After null of capital spending, $0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $0.0 B against reported profit of $0.0 B, leaving free cash of $0.0 B after null of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Versamet Royalties Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Nothing is estimated in place of the missing day-counts, so no cash-cycle chart is drawn.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Versamet Royalties Corporation earns a ROE of 9% in FY25. That is up from a trough of 0% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 66.7% net margin on 0.07× asset turns.
FY25 ROE is 9%, recovered from a FY23 trough of 0% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 66.7% net margin × 0.07× asset turns × 1.83× balance-sheet leverage ≈ 8.5% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
Dividend
Versamet Royalties Corporation pays no dividend. Across the last 9 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Versamet Royalties Corporation does not currently pay a dividend. Across the last 9 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Versamet Royalties Corporation carries total debt of $0.0 B against shareholder equity of $0.4 B as of Mar 26, a debt-to-equity of 0.11 — effectively unlevered. On the annual view that ratio went from 0.33 in FY23 to 0.74 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of $0.0 B against shareholder equity of $0.4 B — a debt-to-equity of 0.11. On the annual view, debt-to-equity went from 0.33 (FY23) to 0.74 (FY25). The returns on this page are earned, not borrowed.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for Versamet Royalties Corporation, so this section names the gap rather than filling it. At typical trading volumes those positions would take about 3.4 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Versamet Royalties Corporation: the Z-score reads 7.91. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 7.91 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 7.91.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gold Resource CorporationGORO | 64.6/100Thin evidence · provisional58% evidence | 26.0/35 Revenue 100% · PAT — · OPM change 62.3 pp 62% evidence | 14.9/25 ROCE 9.6% · OPM 34.1% 76% evidence | 10.1/20 P/E 24× · PEG — 15% evidence | 13.6/20 RS sector 10.2% · RS bench -12.4% · 1Y 78.6%2 of 9 weeks ahead 70% evidence | |
| Exact sum: 26 + 14.9 + 10.1 + 13.6 = 64.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Avino Silver & Gold Mines Ltd.ASM | 60.8/100Mixed-positive evidence65% evidence | ASLEEP | 24.1/35 Revenue 54.8% · PAT 100% · OPM change 6.7 pp 83% evidence | 16.4/25 ROCE 9.1% · OPM 49.6% 76% evidence | 9.9/20 P/E 28.9× · PEG — 15% evidence | 10.4/20 RS sector 1.4% · RS bench -14.9% · 1Y 55.1%1 of 12 weeks ahead 70% evidence |
| Exact sum: 24.1 + 16.4 + 9.9 + 10.4 = 60.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Compañía de Minas Buenaventura S.A.A.BVN | 60.6/100Thin evidence · provisional58% evidence | ASLEEP | 20.2/35 Revenue — · PAT — · OPM change 22.2 pp 45% evidence | 13.1/25 ROCE 4% · OPM 52.7% 76% evidence | 11.3/20 P/E 6.6× · PEG — 15% evidence | 16.0/20 RS sector 15.5% · RS bench -2.5% · 1Y 76%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 13.1 + 11.3 + 16 = 60.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Vox Royalty Corp.VOXR | 57.5/100Thin evidence · provisional58% evidence | ASLEEP | 24.9/35 Revenue 100% · PAT — · OPM change 40.5 pp 62% evidence | 13.1/25 ROCE 7.6% · OPM 44.4% 76% evidence | 11.0/20 P/E 12.5× · PEG — 15% evidence | 8.5/20 RS sector 0% · RS bench -15% · 1Y 36.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 24.9 + 13.1 + 11 + 8.5 = 57.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Triple Flag Precious Metals Corp.TFPM | 56.7/100Mixed-positive evidence81% evidence | BASING | 24.2/35 Revenue 54.1% · PAT 100% · OPM change 12.7 pp 83% evidence | 14.7/25 ROCE 5% · OPM 66.9% 76% evidence | 9.4/20 P/E 23× · PEG 1.9 65% evidence | 8.4/20 RS sector -1.7% · RS bench -15.9% · 1Y 13%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 14.7 + 9.4 + 8.4 = 56.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Metalla Royalty & Streaming Ltd.MTA | 55.6/100Mixed-positive evidence61% evidence | TURNING | 18.8/35 Revenue 85.7% · PAT — · OPM change 25 pp 62% evidence | 7.7/25 ROCE 0.1% · OPM 12.2% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 19.1/20 RS sector 16.5% · RS bench -0.4% · 1Y 83%2 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 7.7 + 10 + 19.1 = 55.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Hecla Mining CompanyHL | 54.8/100Mixed-positive evidence71% evidence | ASLEEP | 27.1/35 Revenue 66.3% · PAT 100% · OPM change 37.4 pp 83% evidence | 13.3/25 ROCE 6.3% · OPM 46% 76% evidence | 9.2/20 P/E 45.4× · PEG — 15% evidence | 5.2/20 RS sector -1% · RS bench -17.8% · 1Y 102.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 27.1 + 13.3 + 9.2 + 5.2 = 54.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -1% and the one-year return is 102.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8McEwen Inc.MUX | 47.4/100Thin evidence · provisional58% evidence | ASLEEP | 17.4/35 Revenue 40.2% · PAT — · OPM change 13.5 pp 62% evidence | 8.3/25 ROCE -0.3% · OPM 14.7% 76% evidence | 10.6/20 P/E 16.4× · PEG — 15% evidence | 11.1/20 RS sector 1.6% · RS bench -14.5% · 1Y 83%0 of 12 weeks ahead 70% evidence |
| Exact sum: 17.4 + 8.3 + 10.6 + 11.1 = 47.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Elemental Royalty CorporationELE | 40.2/100Mixed-negative evidence65% evidence | BASING | 11.3/35 Revenue 100% · PAT -125% · OPM change -10.3 pp 83% evidence | 10.2/25 ROCE 1.2% · OPM 27.3% 76% evidence | 8.5/20 P/E 282.8× · PEG — 15% evidence | 10.2/20 RS sector 0.8% · RS bench -13.9% · 1Y 14.6%0 of 12 weeks ahead 70% evidence |
| Exact sum: 11.3 + 10.2 + 8.5 + 10.2 = 40.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Comstock Inc.LODE | 37.7/100Thin evidence · provisional54% evidence | FADING | 11.1/35 Revenue -100% · PAT — · OPM change -1957.2 pp 62% evidence | 7.7/25 ROCE -5.9% · OPM — 61% evidence | 11.5/20 P/E 1.4× · PEG — 15% evidence | 7.4/20 RS sector -1.5% · RS bench -15% · 1Y 0.3%8 of 12 weeks ahead 70% evidence |
| Exact sum: 11.1 + 7.7 + 11.5 + 7.4 = 37.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Versamet Royalties Corporationthis pageVMET | 56.6/100Thin evidence · provisional44% evidence | ASLEEP | 21.6/35 Revenue 100% · PAT — · OPM change 1.6 pp 62% evidence | 15.3/25 ROCE 6.8% · OPM 90.6% 76% evidence | 9.7/20 P/E 30.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y 78.1%6 of 12 weeks ahead 0% evidence |
| Exact sum: 21.6 + 15.3 + 9.7 + 10 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Solaris Resources Inc.SLSR | 49.1/100Thin evidence · provisional44% evidence | ASLEEP | 20.6/35 Revenue — · PAT — · OPM change — 33% evidence | 6.1/25 ROCE -10.5% · OPM — 61% evidence | 9.0/20 P/E 45.5× · PEG — 15% evidence | 13.4/20 RS sector 6.9% · RS bench -9.5% · 1Y 53.5%0 of 12 weeks ahead 70% evidence |
| Exact sum: 20.6 + 6.1 + 9 + 13.4 = 49.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Guardian Metal Resources PLCGMTL | 41.5/100Thin evidence · provisional20% evidence | ASLEEP | 13.4/35 Revenue — · PAT — · OPM change — 24% evidence | 8.1/25 ROCE -9.7% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 7 weeks ahead 0% evidence |
| Exact sum: 13.4 + 8.1 + 10 + 10 = 41.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Silver Bow Mining Corp.SBMT | 38.7/100Thin evidence · provisional27% evidence | ASLEEP | 13.5/35 Revenue — · PAT — · OPM change — 33% evidence | 5.2/25 ROCE -13.8% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 2 weeks ahead 0% evidence |
| Exact sum: 13.5 + 5.2 + 10 + 10 = 38.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Integra Resources Corp.ITRG | 38.6/100Thin evidence · provisional50% evidence | ASLEEP | 14.9/35 Revenue — · PAT — · OPM change 7.4 pp 39% evidence | 11.3/25 ROCE 6% · OPM 26.6% 76% evidence | 8.7/20 P/E 68.3× · PEG — 15% evidence | 3.7/20 RS sector -22.5% · RS bench -34.5% · 1Y 39.9%0 of 12 weeks ahead 70% evidence |
| Exact sum: 14.9 + 11.3 + 8.7 + 3.7 = 38.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Perpetua Resources Corp.PPTA | 35.7/100Thin evidence · provisional50% evidence | ASLEEP | 19.2/35 Revenue — · PAT — · OPM change — 33% evidence | 5.7/25 ROCE -12.2% · OPM — 61% evidence | 9.4/20 P/E 42.7× · PEG — 15% evidence | 1.4/20 RS sector -12.2% · RS bench -25.9% · 1Y 22.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 5.7 + 9.4 + 1.4 = 35.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Platinum Group Metals Ltd.PLG | 34.3/100Thin evidence · provisional44% evidence | BASING | 13.0/35 Revenue — · PAT — · OPM change — 33% evidence | 7.5/25 ROCE -3.2% · OPM — 61% evidence | 10.8/20 P/E 12.6× · PEG — 15% evidence | 3.0/20 RS sector -27.8% · RS bench -38.6% · 1Y -9.2%0 of 12 weeks ahead 70% evidence |
| Exact sum: 13 + 7.5 + 10.8 + 3 = 34.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Versamet Royalties Corporation's stock price today?
Versamet Royalties Corporation trades at $9.6, +78.1% over the past year. The company is valued at $1.0 B. The stock sits at 52% of its 52-week range of $5–$14, −6.6% versus its 200-day average. Against the S&P 500 it has been behind on a trailing-13-week view for 5 weeks. — as of 5 August 2026.
What were Versamet Royalties Corporation's latest quarterly results?
Versamet Royalties Corporation reported revenue of $0.0 B and net profit of $0.0 B for the Mar 26 quarter. Earnings per share were $0.13. The operating margin was 100.0%. — as of 5 August 2026.
What is Versamet Royalties Corporation's revenue?
Versamet Royalties Corporation reported revenue of $0.0 B in the Mar 26 quarter. For the full FY25 fiscal year, revenue was $0.0 B (+200.0%). — as of 5 August 2026.
What is Versamet Royalties Corporation's profit?
Versamet Royalties Corporation earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. The operating margin ran 100.0% in the latest quarter. — as of 5 August 2026.
What is Versamet Royalties Corporation's market cap?
Versamet Royalties Corporation's market capitalisation is $1.0 B at a stock price of $9.6. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Versamet Royalties Corporation pay a dividend?
No — Versamet Royalties Corporation has declared no dividend per share in any of its last 9 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
How is Versamet Royalties Corporation performing?
Versamet Royalties Corporation's latest readings are below. Against the S&P 500 it has been behind on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
Is Versamet Royalties Corporation beating the market?
Not lately — on a trailing-13-week view Versamet Royalties Corporation is currently behind the S&P 500 (5 weeks and counting; last ahead the week of 2026-07-02), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 11 months the stock moved +78% against the S&P 500's +20% — ahead of the index over the full window. — as of 5 August 2026.
Will Versamet Royalties Corporation's stock price go up?
This page publishes no price forecast for Versamet Royalties Corporation. What it measures instead: the stock price is $9.6. Direction is not something this site claims to know. — as of 5 August 2026.
Does Versamet Royalties Corporation have too much debt?
No — Versamet Royalties Corporation's debt-to-equity is 0.12. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 5 August 2026.
What is Versamet Royalties Corporation's cash flow?
Versamet Royalties Corporation generated $0.0 B of operating cash flow in FY25 and $0.0 B of free cash flow after null of capital spending. Reported profit that year was $0.0 B, so operating cash ran ahead of profit. — as of 5 August 2026.
How financially safe is Versamet Royalties Corporation?
On the balance sheet, the Z-score reads 7.91 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is Versamet Royalties Corporation in its business cycle?
Versamet Royalties Corporation's FY25 operating margin was 133.3%, against a 2-year band of 0.0%–133.3%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 100.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Versamet Royalties Corporation story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Versamet Royalties Corporation a stock worth studying right now?
This is not investment advice. The machine read: Versamet Royalties Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.